KCNQ1OT1 and cardiac hypertrophy: For instance, inhibition of KCNQ1OT1 by hsa-miR-140-3P exacerbates ischemia–reperfusion injury [44], and hsa-miR-140-3p inhibits cardiac hypertrophy through targeting Gata4 [45].